Could a migraine medicine help heal spinal cord injuries?

NCT ID NCT06677229

Recruiting now Disease control Sponsor: Technophage, SA Source: ClinicalTrials.gov ↗

First seen Oct 01, 2025 · Last updated May 25, 2026 · Updated 25 times

Summary

This study tests a drug called TZ-161 (Eletriptan hydrobromide), originally used for migraines, to see if it can help people with recent spinal cord injuries. About 28 adults aged 18-65 with a thoracic spinal injury will receive the drug within 24 hours of injury. The main goal is to check safety and side effects, while also looking for signs of recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Universitario La Paz
RECRUITING

Madrid, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hospital Universitario Reina Sofia
RECRUITING

Córdoba, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE SPINAL CORD INJURY (SCI)